Sore throats and dry coughs are more prevalent symptoms associated with the flu. With the severe 2012-2013 flu season to date, that means a healthy amount of lozenge sales. One of the bigger winners across the top 10 vendors is Reckitt Benckiser, which launched Cepacol Sensations this fall. The product line contains a lower amount of numbing medication than traditional Cepacol products, yet still provides either an instantly cooling, warming or refreshing sensation. Sales of all Reckitt Benckiser lozenges totaled $10.9 million, up 67.6%.
The article above is part of the DSN Category Review Series. For the complete Cough-Cold Sell-Through Report, including extensive charts, data and more analysis, click here.